Background
Methods
Construction and validation process of SMSTP
Phase 1: Development of the SMSTP
-
Step 1: Construction of the questionnaire items
-
Step 2: Item analysis
-
Step 3: Exploratory Factor Analysis
Phase 2: Validation of the SMSTP
-
Step 4: Reliability analysisInternal consistency and test–retest reliability were assessed to determine the reliability of the SMSTP. Internal consistency was determined by the degree of inter-relatedness among items and was assessed using Cronbach’s alpha [42]. Cronbach’s α values > 0.60 were considered acceptable, and those > 0.7 were considered satisfactory [43, 44]. Fifty participants in SMSTP testing returned after 2 weeks and were assessed for test–retest reliability. The test–retest reliability index was based on the intraclass correlation coefficient (ICC), and the 95% confidence interval was calculated. An ICC ≥ 0.7 indicated good test–retest reliability [45, 46].
-
Step 5: ValidityContent and construct validity of the SMSTP were assessed. Content validity was calculated based on the correlation between each item and dimensions using Pearson’s correlation, with values > 0.8 considered very strong, values between 0.6 and 0.8 considered strong, and values between 0.3 and 0.6 considered moderate [47]. Additionally, confirmatory factor analysis (CFA) was used to evaluate construct validity, which was estimated using multiple fit indices, such as relative chi-square and degrees of freedom (χ2/df), comparative fit index (CFI), normed fit index (NFI), incremental fit index (IFI), goodness of fit index (GFI), adjusted goodness of fit index (AGFI), root mean square error of approximation (RMSEA), and standardized root means square residual (SRMR). CFI > 0.90, NFI > 0.90, IFI > 0.90, GFI > 0.95, AGFI > 0.90, and RMSEA and SRMR < 0.06 indicated a good fit (SRMR < 0.08 was acceptable) [48‐50]. Convergent and discriminant validity were also analyzed to evaluate construct validity. Convergent validity was evaluated using the average variance extracted (AVE), with an AVE > 0.7 indicating good convergent validity. We evaluated discriminant validity using two criteria: (1) The Fornell-Larcker criterion, which states that the discriminant validity of AVEs is supported by their square root being higher than their inter-construct correlations [51], and (2) the heterotrait–monotrait (HTMT) ratio, in which a value of < 0.85 reflects the presence of discriminant validity [52].
Data collection
Participants
Data analysis
Results
Demographic characteristics of the participants
Demographic characteristics | Total | Phase 1 (n = 231) | Phase 2 (n = 231) | χ2 | p |
---|---|---|---|---|---|
Gender | |||||
Male | 258 (55.8) | 126 (54.5) | 132 (57.1) | 2.794 | 0.574 |
Female | 204 (44.2) | 105 (45.5) | 99 (42.9) | ||
Age | |||||
15–17 | 32 (6.9) | 17 (7.4) | 15 (6.5) | 2.177 | 0.674 |
18–39 | 320 (69.3) | 163 (70.6) | 157 (67.9) | ||
40–59 | 97 (21.0) | 43 (18.6) | 54 (23.4) | ||
≥ 60 | 13 (2.8) | 8 (3.4) | 5 (2.2) | ||
Ethnicity | |||||
Han race | 335 (72.5) | 159 (68.8) | 176 (76.2) | 3.318 | 0.076 |
Others | 127 (27.5) | 72 (31.2) | 55 (23.8) | ||
Residence | |||||
Urban | 161 (34.8) | 77 (33.3) | 84 (36.4) | 0.467 | 0.494 |
Rural | 301 (65.2) | 154 (66.7) | 147 (63.6) | ||
Registered information | |||||
Resident | 411 (89.0) | 200 (86.6) | 211 (91.3) | 2.667 | 0.102 |
Migrant | 51 (11.0) | 31 (13.4) | 20 (8.7) | ||
Marital status | |||||
Unmarried | 283 (61.3) | 148 (64.1) | 135 (58.4) | 1.609 | 0.477 |
Married | 167 (36.1) | 77 (33.3) | 90 (39.0) | ||
Divorced/Widowed | 12 (2.6) | 6 (2.6) | 6 (2.6) | ||
Education | |||||
Primary and below | 67 (14.5) | 35 (15.2) | 32 (13.9) | 0.339 | 0.844 |
Junior middle school | 129 (27.9) | 66 (28.6) | 63 (27.2) | ||
High school and above | 266 (57.6) | 130 (56.3) | 136 (58.9) | ||
Occupation | |||||
Staff/Cadre/Retire | 106 (22.9) | 49 (21.2) | 57 (24.7) | 4.954 | 0.138 |
Self-employed | 61 (13.2) | 29 (12.6) | 32 (13.8) | ||
Farmer/Migrant worker | 107 (23.2) | 65 (28.1) | 42 (18.2) | ||
Student | 170 (36.8) | 81 (35.1) | 89 (38.5) | ||
Others | 18 (3.9) | 7 (3.0) | 11 (4.8) |
Item analysis
Dimensions | Item contents (brief description in English) | Never | Only rarely | Sometimes | Quite often | Always |
---|---|---|---|---|---|---|
Adherence to treatment behavior | Item1:Medication-taking record card filled | |||||
Item2: Taking medications following prescription | ||||||
Item3:Taking medications when going out | ||||||
Item4: Keeping drugs correctly | ||||||
Item5:Addressing adverse effects of medications correctly | ||||||
Item6: Taking medications consistently | ||||||
Item7: Regular following-up sputum microscopy | ||||||
Supportive behavior | Item8:Abstaining from smoking | |||||
Item9:Abstaining from alcohol drinking | ||||||
Item10:Keeping adequate sleep | ||||||
Item11: Avoiding overexertion | ||||||
Item12:Keeping proper exercise | ||||||
Item13: Keeping adequate nutrition | ||||||
Transmission prevention behavior | Item14:Not spitting indiscriminately | |||||
Item15: Reducing frequency of presence in public | ||||||
Item16: Wearing respirator in public during in infective phrase of disease | ||||||
Item17:Disposing sputum with safe method | ||||||
Item18:Covering face when sneezing/cough/speaking loudly | ||||||
Item19: Informing contact of TB status | ||||||
Item20: Ventilating their room |
Dimension | Item (brief description in English) | Mean (SD) | Critical value | Item-total correlation coefficient |
---|---|---|---|---|
Adherence to treatment behavior | Item 1: Medication-taking record card filled | 3.97 ± 1.38 | 0.823 | 0.060 |
Item 2: Taking medications following prescription | 4.00 ± 1.29 | 14.600** | 0.676** | |
Item 3: Taking medications when going out | 3.07 ± 1.39 | 0.372 | 0.035 | |
Item 4: Keeping drugs correctly | 3.21 ± 1.46 | 10.648** | 0.603** | |
Item 5: Addressing adverse effects of medications correctly | 2.94 ± 1.40 | 12.589** | 0.602** | |
Item 6: Taking medications consistently | 3.14 ± 1.49 | 13.746** | 0.616** | |
Item 7: Regularly following-up sputum | 2.99 ± 1.45 | 14.952** | 0.661** | |
Supportive behavior | Item 8: Abstaining from smoking | 2.95 ± 1.14 | 11.471** | 0.600** |
Item 9: Abstaining from alcohol drinking | 3.16 ± 1.23 | 10.190** | 0.575** | |
Item 10: Maintaining adequate sleep | 2.90 ± 1.05 | 10.332** | 0.578** | |
Item 11: Avoiding overexertion | 3.17 ± 1.25 | 12.533** | 0.643** | |
Item 12: Keeping proper exercise | 2.79 ± 0.91 | 11.522** | 0.620** | |
Item 13: Maintaining adequate nutrition | 3.19 ± 1.30 | 11.406** | 0.624** | |
Transmission prevention behavior | Item 14: Not spitting indiscriminately | 2.82 ± 0.98 | 10.505** | 0.574** |
Item 15: Reducing frequency of presence in public | 3.69 ± 1.05 | 11.428** | 0.735** | |
Item 16: Wearing respirator in public during infective phase of disease | 4.13 ± 1.21 | 5.386** | 0.407** | |
Item 17: Disposing sputum with safe method | 3.39 ± 1.21 | 10.573** | 0.653** | |
Item 18: Covering face when sneezing/coughing/speaking loudly | 3.38 ± 1.17 | 11.425** | 0.685** | |
Item 19: Informing contact of TB status | 3.24 ± 1.16 | 9.520** | 0.599** | |
Item 20: Ventilating their room | 3.32 ± 1.16 | 10.046** | 0.595** |
Exploratory factor analysis
Dimension\Item (brief description in English) | Factor loadings | Eigenvalue | Explained Variance (%) | ||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Dimension 1 (Transmission prevention behavior) | |||||
Item 15: Reducing frequency of presence in public | 0.819 | 0.076 | 0.173 | 6.932 | 26.916 |
Item 16: Wearing respirator in public during in infective phase of disease | 0.847 | 0.179 | 0.231 | ||
Item 17: Disposing sputum with safe method | 0.859 | 0.109 | 0.157 | ||
Item 18: Covering face when sneezing/cough/speaking loudly | 0.856 | 0.129 | 0.192 | ||
Item 19: Informing contact of TB status | 0.867 | 0.099 | 0.074 | ||
Item 20: Ventilating their room | 0.865 | 0.100 | 0.039 | ||
Dimension 2 (Supportive behavior) | |||||
Item 8: Abstaining from smoking | 0.114 | 0.859 | 0.107 | 3.357 | 26.761 |
Item 9: Abstaining from alcohol drinking | 0.062 | 0.881 | 0.070 | ||
Item 10: Maintaining adequate sleep | 0.038 | 0.843 | 0.139 | ||
Item 11: Avoiding overexertion | 0.197 | 0.851 | 0.089 | ||
Item 12: Keeping proper exercise | 0.117 | 0.864 | 0.064 | ||
Item 13: Maintaining adequate nutrition | 0.154 | 0.837 | 0.171 | ||
Dimension 3 (Adherence to treatment behavior) | |||||
Item 2: Taking medications following prescription | 0.191 | 0.125 | 0.889 | 2.734 | 22.929 |
Item 4: Keeping drugs correctly | 0.102 | 0.101 | 0.856 | ||
Item 5: Addressing adverse effects of medications correctly | 0.103 | 0.142 | 0.841 | ||
Item 6: Taking medications consistently | 0.142 | 0.088 | 0.857 | ||
Item 7: Regularly following-up sputum microscopy | 0.211 | 0.115 | 0.840 |
Reliability
Cronbach Alpha | ICC (95%CI) | AVE | |
---|---|---|---|
Dimension 1: Transmission prevention behavior | 0.936 | 0.814 (0.693–0.890) | 0.715 |
Dimension 2: Supportive behavior | 0.933 | 0.834 (0.807–0.933) | 0.711 |
Dimension 3: Adherence to treatment behavior | 0.925 | 0.885 (0.807–0.933) | 0.709 |
Total | 0.905 | 0.897 (0.825–0.940) |
Validity
Content validity
Dimension | Item | Transmission prevention behavior | Supportive behavior | Adherence to treatment behavior |
---|---|---|---|---|
Transmission prevention behavior | 1 | 0.275** | 0.344** | |
Item 15: Reducing frequency of presence in public | 0.204** | 0.849** | 0.315** | |
Item 16: Wearing respirator in public during infective phase of disease | 0.312** | 0.887** | 0.388** | |
Item 17: Disposing sputum with safe method | 0.237** | 0.880** | 0.311** | |
Item 18: Covering face when sneezing/coughing/speaking loudly | 0.262** | 0.885** | 0.347** | |
Item 19: Informing contact of TB status | 0.220** | 0.870** | 0.238** | |
Item 20: Ventilating their room | 0.216** | 0.863** | 0.207** | |
Supportive behavior | 0.275** | 1 | 0.267** | |
Item 8: Abstaining from smoking | 0.878** | 0.241** | 0.236** | |
Item 9: Abstaining from alcohol drinking | 0.887** | 0.190** | 0.195** | |
Item 10: Maintaining adequate sleep | 0.849** | 0.175** | 0.249** | |
Item 11: Avoiding overexertion | 0.882** | 0.312** | 0.233** | |
Item 12: Keeping proper exercise | 0.865** | 0.236** | 0.198** | |
Item 13: Maintaining adequate nutrition | 0.855** | 0.286** | 0.297** | |
Adherence to treatment behavior | 0.344** | 0.267** | 1 | |
Item 2: Taking medications following prescription | 0.346** | 0.346** | 0.915** | |
Item 4: Keeping drugs correctly | 0.256** | 0.256** | 0.868** | |
Item 5: Addressing adverse effects of medications correctly | 0.261** | 0.261** | 0.857** | |
Item 6: Taking medications consistently | 0.292** | 0.292** | 0.873** | |
Item 7: Regularly following-up sputum | 0.355** | 0.355** | 0.873** |
Construct validity
Dimension1: Transmission prevention behavior | Dimension2: Supportive behavior | Dimension3: Adherence to treatment behavior | |
---|---|---|---|
Dimension1: Transmission prevention behavior | 0.845 | 0.297 | 0.377 |
Dimension2: Supportive behavior | 0.274 | 0.843 | 0.297 |
Dimension3: Adherence to treatment behavior | 0.351 | 0.275 | 0.842 |